These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field]. Toyonaga Y, Ishihara T, Sano T, Tezuka T, Nakamura H. Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496 [Abstract] [Full Text] [Related]
4. [Pharmacokinetic, bacteriological and clinical evaluations of cefdinir 10% fine granules in pediatrics]. Iwai N, Nakamura H, Miyazu M, Watanabe Y. Jpn J Antibiot; 1991 Oct; 44(10):1119-33. PubMed ID: 1762168 [Abstract] [Full Text] [Related]
6. [Fundamental and clinical studies on cefixime (5% granules) in the pediatric field]. Toyonaga Y, Sugita M, Nakamura H, Joh K, Takahashi T, Kurosu Y, Hori M. Jpn J Antibiot; 1986 Apr; 39(4):1055-75. PubMed ID: 3761537 [Abstract] [Full Text] [Related]
7. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field]. Toyonaga Y, Ishihara T, Tezuka T, Nakamura H. Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846 [Abstract] [Full Text] [Related]
8. [Pharmacokinetics and clinical effects of cefdinir 5% fine granules in pediatrics]. Motohiro T, Handa S, Yamada S, Oki S, Tsumura N, Yoshinaga Y, Aramaki M, Shimada Y, Kawakami A, Koga T. Jpn J Antibiot; 1990 Oct; 43(10):1813-35. PubMed ID: 2086819 [Abstract] [Full Text] [Related]
10. [Fundamental and clinical studies on cefixime in the pediatric field]. Nakashima S, Hayakawa F, Nakashima T, Miyachi Y, Hakamada S, Kuno K. Jpn J Antibiot; 1986 Apr; 39(4):1076-86. PubMed ID: 3761538 [Abstract] [Full Text] [Related]
11. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field]. Toyonaga Y, Koizumi M, Imai H, Sugita M, Takahashi T, Fukushima Y, Yamasaki M, Hori M. Jpn J Antibiot; 1989 Jul; 42(7):1519-46. PubMed ID: 2810728 [Abstract] [Full Text] [Related]
13. In vitro antibacterial activity of FK482, a new orally active cephalosporin. Mine Y, Kamimura T, Watanabe Y, Tawara S, Matsumoto Y, Shibayama F, Kikuchi H, Takaya T, Kuwahara S. J Antibiot (Tokyo); 1988 Dec; 41(12):1873-87. PubMed ID: 3264828 [Abstract] [Full Text] [Related]
14. [Pharmacokinetic and clinical studies of cefdinir in the pediatric field. Pediatric Study Group of Cefdinir]. Fujii R, Yoshioka H, Fujita K, Sakata H, Nire H, Iseki K, Murono K, Takahashi Y, Wagatsuma Y, Fukushima N. Jpn J Antibiot; 1991 Oct; 44(10):1168-91. PubMed ID: 1762172 [Abstract] [Full Text] [Related]
15. [Basic and clinical studies on S-1108 in pediatric field]. Motohiro T, Handa S, Yamada S, Oki S, Yoshinaga Y, Aramaki M, Oda K, Sakata Y, Kato H, Yamashita F. Jpn J Antibiot; 1993 Dec; 46(12):1122-44. PubMed ID: 8107277 [Abstract] [Full Text] [Related]
16. [Laboratory and clinical studies of cefdinir 5% and 10% fine granules in pediatric field]. Nishimura T, Tabuki K, Aoki S, Takagi M. Jpn J Antibiot; 1991 Oct; 44(10):1142-57. PubMed ID: 1762170 [Abstract] [Full Text] [Related]
17. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field]. Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M. Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522 [Abstract] [Full Text] [Related]
18. [Pharmacokinetic, bacteriological and clinical studies of SY5555 in the pediatric field]. Motohiro T, Handa S, Yamada S, Oki S, Yoshinaga Y, Oda K, Sakata Y, Kato H, Yamashita F, Imai S. Jpn J Antibiot; 1995 Feb; 48(2):238-60. PubMed ID: 7745814 [Abstract] [Full Text] [Related]